AN2 Therapeutics, Inc. (ANTX) Tops Q2 EPS by 13c
Tweet
Share
E-mailGet Alerts ANTX Hot Sheet
Join SI Premium – FREE
AN2 Therapeutics, Inc. (NASDAQ: ANTX) reported Q2 EPS of ($0.48), $0.13 better than the analyst estimate of ($0.61).
For earnings history and earnings-related data on AN2 Therapeutics, Inc. (ANTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Rosenblatt Reiterates Buy Rating on NVIDIA (NVDA) into Earnings
- Strategy (MSTR) August 28 weekly calls active amid wide share price and bitcoin movement
- Forex.com launches overnight Japan stock CFD trading in Tokyo
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
